Literature DB >> 16103220

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Karin List1, Roman Szabo, Alfredo Molinolo, Virote Sriuranpong, Vivien Redeye, Tricia Murdock, Beth Burke, Boye S Nielsen, J Silvio Gutkind, Thomas H Bugge.   

Abstract

Overexpression of the type II transmembrane serine protease matriptase is a highly consistent feature of human epithelial tumors. Here we show that matriptase possesses a strong oncogenic potential when unopposed by its endogenous inhibitor, HAI-1. Modest orthotopic overexpression of matriptase in the skin of transgenic mice caused spontaneous squamous cell carcinoma and dramatically potentiated carcinogen-induced tumor formation. Matriptase-induced malignant conversion was preceded by progressive interfollicular hyperplasia, dysplasia, follicular transdifferentiation, fibrosis, and dermal inflammation. Furthermore, matriptase induced activation of the pro-tumorigenic PI3K-Akt signaling pathway. This activation was frequently accompanied by H-ras or K-ras mutations in carcinogen-induced tumors, whereas matriptase-induced spontaneous carcinoma formation occurred independently of ras activation. Increasing epidermal HAI-1 expression completely negated the oncogenic effects of matriptase. The data implicate dysregulated matriptase expression in malignant epithelial transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103220      PMCID: PMC1186192          DOI: 10.1101/gad.1300705

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  52 in total

Review 1.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.

Authors:  C Chang; Z Werb
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 2.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis.

Authors:  L H Engelholm; B S Nielsen; S Netzel-Arnett; H Solberg; X D Chen; J M Lopez Garcia; C Lopez-Otin; M F Young; H Birkedal-Hansen; K Danø; L R Lund; N Behrendt; T H Bugge
Journal:  Lab Invest       Date:  2001-10       Impact factor: 5.662

5.  Functional roles of Akt signaling in mouse skin tumorigenesis.

Authors:  Carmen Segrelles; Sergio Ruiz; Paloma Perez; Cristina Murga; Mirentxu Santos; Irina V Budunova; Jesús Martínez; Fernando Larcher; Thomas J Slaga; J Silvio Gutkind; Jose L Jorcano; Jesús M Paramio
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

6.  N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease.

Authors:  E G Cho; M G Kim; C Kim; S R Kim; I S Seong; C Chung; R H Schwartz; D Park
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

7.  Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development.

Authors:  A Ramírez; A Bravo; J L Jorcano; M Vidal
Journal:  Differentiation       Date:  1994-11       Impact factor: 3.880

8.  FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.

Authors:  H Hennings; A B Glick; D T Lowry; L S Krsmanovic; L M Sly; S H Yuspa
Journal:  Carcinogenesis       Date:  1993-11       Impact factor: 4.944

9.  Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.

Authors:  C Parr; W G Jiang
Journal:  Int J Oncol       Date:  2001-10       Impact factor: 5.650

10.  Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.

Authors:  R Murillas; F Larcher; C J Conti; M Santos; A Ullrich; J L Jorcano
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  100 in total

1.  Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade.

Authors:  Zhenghong Xu; Ya-Wen Chen; Aruna Battu; Paul Wilder; David Weber; Wenbo Yu; Alexander D Mackerell; Li-Mei Chen; Karl X Chai; Michael D Johnson; Chen-Yong Lin
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 3.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

4.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

5.  Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.

Authors:  Shang-Ru Wu; Tai-Shan Cheng; Wen-Chi Chen; Hsin-Yi Shyu; Chun-Jung Ko; Hsiang-Po Huang; Chen-Hsin Teng; Chia-Hau Lin; Michael D Johnson; Chen-Yong Lin; Ming-Shyue Lee
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 6.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

7.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

8.  Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Boye Schnack Nielsen; Thomas H Bugge
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1).

Authors:  Christopher J Farady; Jeonghoon Sun; Molly R Darragh; Susan M Miller; Charles S Craik
Journal:  J Mol Biol       Date:  2007-04-04       Impact factor: 5.469

10.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.